The present invention encompasses albumin fusion proteins. Nucleic acid molecules
encoding the albumin fusion proteins of the invention are also encompassed by the
invention, as are vectors containing these nucleic acids, host cells transformed
with these nucleic acids vectors, and methods of making the albumin fusion proteins
of the invention and using these nucleic acids, vectors, and/or host cells. Additionally
the present invention encompasses pharmaceutical compositions comprising albumin
fusion proteins and methods of treating, preventing, or ameliorating diseases,
disordrs or conditions using albumin fusion proteins of the invention.
